Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
| dc.rights.license | open | en_US |
| dc.contributor.author | GEFARD-GONTIER, Emilie | |
| dc.contributor.author | MARKICH, Romane | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | ZYSMAN, Maeva | |
| dc.contributor.author | VEILLON, Remi | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | DASTE, Amaury | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| hal.structure.identifier | Immunology from Concept and Experiments to Translation [ImmunoConcept] | |
| dc.contributor.author | DOMBLIDES, Charlotte | |
| dc.contributor.author | SIONNEAU, Baptiste | |
| dc.contributor.author | GROSS-GOUPIL, Marine | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| hal.structure.identifier | Immunology from Concept and Experiments to Translation [ImmunoConcept] | |
| dc.contributor.author | LEFORT, Felix | |
| hal.structure.identifier | Biothérapies des maladies génétiques et cancers | |
| dc.contributor.author | PREY, Sorilla | |
| dc.contributor.author | DUTRIAUX, Caroline | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | GERARD, Emilie | |
| hal.structure.identifier | Biothérapies des maladies génétiques et cancers | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | DOUSSET, Lea | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | PHAM-LEDARD, Anne | |
| dc.contributor.author | BEYLOT-BARRY, Marie | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | SCHAEVERBEKE, Thierry | |
| dc.contributor.author | KOSTINE, Marie | |
| dc.date.accessioned | 2023-02-21T15:43:08Z | |
| dc.date.available | 2023-02-21T15:43:08Z | |
| dc.date.created | 2022-03-19 | |
| dc.date.issued | 2022-11 | |
| dc.identifier.issn | 3407004 | en_US |
| dc.identifier.other | https://link.springer.com/article/10.1007/s00262-022-03180-x | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/172036 | |
| dc.language.iso | EN | en_US |
| dc.title.en | Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1007/s00262-022-03180-x | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Immunologie | en_US |
| dc.identifier.pubmed | 35305123 | en_US |
| bordeaux.journal | Cancer Immunology, Immunotherapy | en_US |
| bordeaux.page | 2609-2618 | en_US |
| bordeaux.volume | 71 | en_US |
| bordeaux.hal.laboratories | ImmunoConcEpT - UMR 5164 | en_US |
| bordeaux.issue | 11 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | CNRS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| hal.export | false | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.date=2022-11&rft.volume=71&rft.issue=11&rft.spage=2609-2618&rft.epage=2609-2618&rft.eissn=3407004&rft.issn=3407004&rft.au=GEFARD-GONTIER,%20Emilie&MARKICH,%20Romane&ZYSMAN,%20Maeva&VEILLON,%20Remi&DASTE,%20Amaury&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||